- RecruitingPHASE4
Staphylococcus Aureus Network Adaptive Platform Trial
The SNAP trial is studying different treatments for a serious blood infection called Staphylococcus aureus (S. aureus) to find out which ones work best. It aims to reduce serious illness and death by testing various medicines and approaches.
For: Staphylococcus Aureus BacteremiaUnited States · Australia · Canada - Ongoing, recruitingTherapeutic use (Phase IV)
Pharmacokinetics study of Cefazolin in haemodialysis (CEFAZODIAL)
This study looks at how a common antibiotic called Cefazolin works in patients on dialysis who have an infection. We want to find the best way to give the medicine so it stays at the right level in their body to fight the infection effectively.
For: Chronic haemodialysis patients suffering from infection.France - AuthorisedTherapeutic use (Phase IV)
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol - A multi-national pharmacokinetic/pharmacodynamic cohort study to determine whether contemporary antibiotic dosing for critically ill patients achieves therapeutic exposures.
This study looks at how well antibiotics work in very sick patients. Researchers want to make sure these important medicines reach the right levels in the body to fight serious infections effectively and safely. It's about getting the dose just right.
For: Serious infections in critically ill patients treated with antibioticsFrance